Indianapolis, IN, United States of America

Andrew David Carlson


Average Co-Inventor Count = 2.5

ph-index = 4

Forward Citations = 75(Granted Patents)


Company Filing History:


Years Active: 2000-2003

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Andrew David Carlson: Innovator in Activated Protein C Formulations

Introduction

Andrew David Carlson is a prominent inventor based in Indianapolis, Indiana, known for his significant contributions to the field of pharmaceutical formulations. With a total of five patents to his name, Carlson has demonstrated a commitment to advancing medical science, specifically in the area of activated protein C.

Latest Patents

Carlson's latest patents focus on the development of innovative activated protein C formulations. One of his key inventions is a formulation that enhances the stability of activated protein C, resulting in fewer degradation products over time. This advancement is crucial for ensuring the efficacy and safety of pharmaceuticals containing activated protein C. Another important patent addresses the reduction of autodegradation during the processing and purification of activated protein C. His method involves maintaining specific ionic strength and pH levels during the preparation of aqueous activated protein C solutions, which contributes to improved processing outcomes.

Career Highlights

Currently, Andrew David Carlson is employed at Eli Lilly and Company, a leading global pharmaceutical company. His expertise in developing stable and effective pharmaceutical formulations has contributed significantly to the company's innovative research efforts. Throughout his career, Carlson has focused on bridging scientific research with practical applications in the pharmaceutical industry, making impactful advancements that benefit patients and healthcare systems.

Collaborations

Carlson has collaborated with notable colleagues, including Theodore Arsay Sheliga and Jeffrey C. Baker, to further enhance the impact of their innovations in activated protein C formulations. These collaborations underscore the value of teamwork in advancing scientific research and development within the pharmaceutical sector.

Conclusion

Andrew David Carlson’s innovative work in stabilized activated protein C formulations exemplifies the important role of inventors in the pharmaceutical field. With a solid portfolio of patents and a commitment to scientific advancement, Carlson continues to make significant contributions that have the potential to improve patient outcomes and transform pharmaceutical processes. His collaborations with skilled professionals further reflect the importance of teamwork in driving innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…